Tianjin Tianyao Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Tianjin Pharmaceutical Co., Ltd. was established on December 1, 1999. Listed on the Shanghai Stock Exchange on June 18, 2001, with stock code 600488. The predecessor of Tianjin Pharmaceutical Co., Ltd. was Tianjin Pharmaceutical Factory, founded in 1939. Since the 1950s to 1960s, he has been the first to develop, develop, and produce corticosteroid raw materials in China. He is one of the pioneers of corticosteroid drugs in China and an influential research, production, and export base for corticosteroid raw materials in China. In 2017, the company completed the restructuring project of acquiring Tianjin Jinyao Pharmaceutical Co., Ltd. (referred to as "Jinyao Pharmaceutical"), achieving a strategic transformation from a single "raw material drug" to a "raw material drug and formulation" business with complementary advantages and dual linkage. In 2020, the company acquired 51% equity of Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd. (referred to as "Hubei Tianyao"). Hubei Tianyao mainly produces and sells small and large capacity injections, further enriching the company's product variety and expanding the scale of formulation products. The performance driving force under the "raw material and formulation" dual wheel linkage mode is more significant. The company currently has 17 holding and participating companies with total assets of over 6 billion yuan. The company's main products include more than 40 varieties of corticosteroid APIs, including dexamethasone series, prednisone series, methylprednisolone series, betamethasone series, 23 varieties of amino acid APIs, and 16 dosage forms of drugs, including tablets, small volume injections, ointments, creams, film coating agents, gel, films, suppositories, hard capsules, pills, freeze-dried powder injections, etc. Tianjin Pharmaceutical Co., Ltd. is a national high-tech enterprise and the president unit of the National Steroid Hormone Industry Association. It is one of the earliest raw material drug and preparation production enterprises in China to obtain the GMP certificate for corticosteroid raw materials and the first batch of raw material drugs and preparations in Tianjin to all pass the national GMP certification; The subsidiary Jinyao Pharmaceutical is a national high-tech enterprise and a leading technology enterprise in Tianjin, committed to becoming a domestic research and development and industrial base for corticosteroid preparations; The subsidiary Hubei Tianyao is a national high-tech enterprise and a large-scale professional injection production enterprise in central China. Its small capacity injection products have occupied a leading position in the production and sales of central China for many years. |
| Headquarter | Tianjin |
| Establish Date | 12/1/1999 |
| Listed Code | 600488.SH |
| Listed Date | 6/18/2001 |
| Chairman | Xu Hua. |
| CEO | Li Bookcase. |
| Website | www.kingyork.biz/html/2 |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
